Industry Satellite Symposia
| Thursday 10 June 2021 13:45 - 14:45 (CET) | A look forward: Embracing transformational change in Cystic Fibrosis care Moderator: Francesco Blasi (IT) |
|---|---|
| 13:45 - 13:52 | Welcome and introduction - Francesco Blasi (IT) |
| 13:52 - 14:04 | Born with CF in the 21st century: A journey from fatal to treatable - Marcus Mall (DE) |
| 14:04 - 14:16 | Learnings from turbulent times: Accelerating innovation in CF care - Nick Simmonds (UK) |
| 14:16 - 14:28 | A new era in CF: Building a better picture and picturing a better future - Paul McNally (IE) |
| 14:28 - 14:45 | Panel discussion and Q&A - Francesco Blasi, (IT) |
| Thursday 10 June 2021 17:45 - 18:45 (CET) | Antibiotics and Patient Management in a Changing World Moderator: Francesco Blasi (IT) |
|---|---|
| 17.45 - 17-50 | Introduction - Francesco Blasi (IT) |
| 17.50 -18.05 | The role of antibiotics alongside CFTR modulators - Stuart Elborn (UK) |
| 18.05 -18.20 | Current patient-based approaches to managing CF - Jessica Maetz (FR) |
| 18.20 -18-35 | Virtual management for patients with CF: An effective solution? - Daniel Peckham (UK) |
| 18.35 -18-45 | Live Q&A session and closing (All) |
| Friday 11 June 2021 13:45 - 14:45 | Shifting the boundaries in cystic fibrosis clinical development: A journey of innovation Moderator: Kris De Boeck (BE) |
|---|---|
| 13:45 - 13:50 | Welcome and introduction - Kris De Boeck (BE) |
| 13:50 - 14:03 | The journey continued: What lies on the horizon? - Kris De Boeck (BE) |
| 14:03 - 14:16 | Defining and measuring what matters: Spotlight on sweat chloride - Steve Rowe (US) |
| 14:16 - 14:29 | Clinical development in CF: A new world - Jane Davies (UK) |
| 14:29 - 14:45 | Panel discussion and Q&A - Kris De Boeck (BE) |
| Friday 11 June 2021 17:45 – 18:45 | Future management of respiratory infection in CF: challenges and opportunities |
|---|---|
| 17:45 – 17:50 | Welcome and introduction - Stuart Elborn (UK) |
| 17:50 – 17:55 | Infection and the microbiome - Stuart Elborn (UK) |
| 17:55 – 18:00 | Q&A - Panel |
| 18:00 – 18:05 | CTFR modulators and the microbiome - Charlotte Addy (UK) |
| 18:05 – 18:10 | Q&A - Panel |
| 18:10 – 18:15 | Optimal treatment of early infection in patients with CF - Charlotte Addy (UK) |
| 18:15 – 18:20 | Q&A - Panel |
| 18:20 – 18:25 | Considerations for managing chronic infections - Stuart Elborn (UK) |
| 18:25 – 18:30 | Q&A - Panel |
| 18:30 – 18:35 | The future outlook of CF care - Stuart Elborn (UK) & Charlotte Addy (UK) |
| 18:35 – 18:40 | Q&A - Panel |
| 18:40 – 18:45 | Summary and close - Stuart Elborn (UK) |
Med/Tech Event
| Thursday 10 June 2021 10:10 – 10:45 | Simeox therapy: a new technology for physiotherapy in CF |
|---|---|
| 10:10 – 10:12 | Welcome and Introduction – Laurent Morin (FR) |
| 10:12 – 10:27 | Results of homecare Simeox trial in Pediatric Cystic Fibrosis patients – Dorota Sands (PL) |
| 10:27 – 10:37 | Short term effects of Simeox therapy at the CF center of Ulm: pilot study results – Dorit Fabricius (DE) and Hanna Schmidt (DE) |
| 10:37 – 10:43 | Simeox therapy at each stage of the CF patient care: Main outcomes from European virtual roundtables – Laurent Morin (FR) |
| 10:43 – 10:45 | Closing |